TickerFactsScreenerDevelopers

BIOCRYST PHARMACEUTICALS INC (BCRX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2008: $46.43M2009: $86.27M2010: $65.50M2011: $14.81M2012: -$454.0K2013: -$1.13M2014: $75.64M2015: $47.72M2016: $1.58M2017: $83.77M2018: $49.23M2019: $38.25M2020: -$19.26M2021: -$106.99M2022: -$294.60M2023: -$455.53M2024: -$475.93M2025: -$119.15M-$119.15M
2008Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$119.15M+75.0%
2024-$475.93M-4.5%
2023-$455.53M-54.6%
2022-$294.60M-175.4%
2021-$106.99M-455.4%
2020-$19.26M-150.4%
2019$38.25M-22.3%
2018$49.23M-41.2%
2017$83.77M+5208.4%
2016$1.58M-96.7%
2015$47.72M-36.9%
2014$75.64M+6817.1%
2013-$1.13M-148.0%
2012-$454.0K-103.1%
2011$14.81M-77.4%
2010$65.50M-24.1%
2009$86.27M+85.8%
2008$46.43M—